Ranbaxy Launches India’s First Locally Developed Malaria Drug, Synriam
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories said it expects to follow up its local launch of India’s first locally developed malaria drug, Synriam (arterolane/piperaquine) at home with subsequent launches elsewhere in Asia and in Africa and South America.